ROSE ERIC A MD

SEC source: 0001104659-24-074011 · tm2417742-3_4seq1.xml · derivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,068

Underlying: Common Stock · 17,068 shares

Expires 2034-06-20

SEC source: 0001104659-24-074011 · tm2417742-3_4seq1.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,544

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025.

SEC source: 0001104659-23-083496 · tm2321855-2_4seq1.xml · derivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-07-20

SEC source: 0001213900-23-041642 · ownership.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,325 shares

Expires 2023-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.

SEC source: 0001213900-23-041642 · ownership.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,168

F1 · kind: On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.

F2 · shares: Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise.

F3 · price: Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer.

SEC source: 0001213900-23-041642 · ownership.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.

SEC source: 0001213900-23-006181 · ownership.xml · derivative · entry 5

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,325

Underlying: Common Stock · 2,325 shares

Expires 2023-05-31

F7 · price: Received in the Business Combination in exchange for warrants to purchase 5,000 shares of Legacy Orchestra Common Stock for $0.50 per share.

SEC source: 0001213900-23-006181 · ownership.xml · derivative · entry 4

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,488

Underlying: Common Stock · 3,488 shares

Expires 2032-04-11

F6 · price: Received in the Business Combination in exchange for an incentive stock option to acquire 7,500 shares of Legacy Orchestra Common Stock for $1.89 per share.

F5 · derivative.exercise_date: The incentive stock options vests annually in equal installments over a two-year period starting with the first anniversary of the grant date, subject to the Reporting Person's continuous service through such date. The grant date is April 12, 2022.

SEC source: 0001213900-23-006181 · ownership.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,250

Underlying: Common Stock · 23,250 shares

Expires 2032-08-25

F4 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 50,000 shares of Legacy Orchestra Common Stock for $4.65 per share.

F3 · derivative.exercise_date: The nonstatutory stock options vest over a three-year period as follows: (i) 33% of the underlying shares will vest on the first anniversary of the grant date and (ii) 67% of the underlying shares will vest in equal installments on a quarterly basis, starting on the day of the month of the last month of the first quarter after the first anniversary of the grant date, that is the same day of the month as the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.

SEC source: 0001213900-23-006181 · ownership.xml · derivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,975

Underlying: Common Stock · 6,975 shares

Expires 2029-08-06

F2 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 15,000 shares of Legacy Orchestra Common Stock for $2.00 per share.

SEC source: 0001213900-23-006181 · ownership.xml · derivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,600

Underlying: Common Stock · 18,600 shares

Expires 2028-11-16

F1 · price: These securities were received on the closing date of the merger (the "Business Combination") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the "Merger Agreement"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) ("HSAC2"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation ("Legacy Orchestra"), in exchange for a nonstatutory stock option ("NSO") to acquire 40,000 shares of common stock of Legacy Orchestra ("Legacy Orchestra Common Stock") for $2.00 per share.

SEC source: 0001213900-23-041634 · ownership.xml · derivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,250

Underlying: Common Stock · 23,250 shares

Expires 2032-08-17

F1 · security: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently misstated the expiration date of one class of nonstatutory stock options ("NSOs"). In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to correct the incorrect expiration date in Table II, Column 6 to August 17, 2032; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

F3 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 50,000 shares of Legacy Orchestra Common Stock for $4.65 per share.

F2 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares will vest on the first anniversary of the grant date and (ii) 67% of the underlying shares will vest in equal installments on a quarterly basis starting on the day of the month of the last month of the first quarter after the first anniversary of the grant date, that is the same day of the month as the grant date, subject to the Reporting Person's continuous service through such date. The grant date is August 18, 2022.

SEC source: 0001415889-22-008527 · form4-08122022_010815.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,203

F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

SEC source: 0001415889-22-008527 · form4-08122022_010815.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,516

F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a -Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan.

F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a -Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan.

SEC source: 0001179110-21-008177 · edgar.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,835

F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

SEC source: 0001179110-21-008177 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,100

F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders.

F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001209191-21-041495 · doc4.xml · derivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F2 · derivative.exercise_date: The RSUs were granted on June 16, 2020, and fully vested on the date of, and immediately prior to, the Company's 2021 annual meeting of stockholders.

F2 · derivative.expiration_date: The RSUs were granted on June 16, 2020, and fully vested on the date of, and immediately prior to, the Company's 2021 annual meeting of stockholders.

SEC source: 0001209191-21-041495 · doc4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,068,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

SEC source: 0001179110-20-009048 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,475

F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders.

F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001179110-20-008875 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,814

F1 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

F1 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

SEC source: 0001140361-20-014221 · form4.xml · derivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock, par value $.0001 per share · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock of SIGA Technologies, Inc. (the "Company") on a one for one basis.

F2 · derivative.exercise_date: The RSUs vest on the date of, and immediately prior to, the 2021 annual meeting of the Company's stockholders.

F2 · derivative.expiration_date: The RSUs vest on the date of, and immediately prior to, the 2021 annual meeting of the Company's stockholders.

SEC source: 0001140361-20-012329 · form4.xml · derivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock of SIGA Technologies, Inc. on a one for one basis.

F2 · derivative.exercise_date: The RSUs were granted on May 21, 2019, and vested on the first anniversary of such date.

F2 · derivative.expiration_date: The RSUs were granted on May 21, 2019, and vested on the first anniversary of such date.

SEC source: 0001140361-20-012329 · form4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,053,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-19-021546 · form4.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 100,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 54,501 shares of Common Stock -- granted in the form of RSUs on November 22, 2016 -- in order to satisfy those withholding tax obligations.

F2 · derivative.exercise_date: Represents vesting of certain RSUs granted on November 22, 2016 and the consequent issuance of common stock of the Issuer to the Reporting Person. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. The shares of common stock reported in this Form 4 were issued in respect of RSUs that vested on November 22, 2019. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis.

F2 · derivative.expiration_date: Represents vesting of certain RSUs granted on November 22, 2016 and the consequent issuance of common stock of the Issuer to the Reporting Person. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. The shares of common stock reported in this Form 4 were issued in respect of RSUs that vested on November 22, 2019. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis.

SEC source: 0001140361-19-021546 · form4.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,038,593

F1 · shares: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 54,501 shares of Common Stock -- granted in the form of RSUs on November 22, 2016 -- in order to satisfy those withholding tax obligations.

SEC source: 0001140361-19-021546 · form4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,093,094

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-19-009345 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,236

F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders.

F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001140361-19-009679 · form4.xml · derivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock, par value $.0001 per share · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock of SIGA Technologies, Inc. on a one for one basis.

F2 · derivative.exercise_date: The RSUs vest on the first anniversary of the grant date.

F2 · derivative.expiration_date: The RSUs vest on the first anniversary of the grant date.

SEC source: 0001140361-18-043708 · form4.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock, par value $.0001 per share · 200,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 105,896 shares of Common Stock -- granted in the form of RSUs on November 22, 2016 -- in order to satisfy those withholding tax obligations.

F2 · derivative.exercise_date: Represents vesting of certain RSUs granted on November 22, 2016 and the consequent issuance of Common Stock of the Issuer to the Reporting Person. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. The shares of Common Stock reported in this Form 4 were issued in respect of RSUs that vested on November 22, 2017 and November 22, 2018. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis.

F2 · derivative.expiration_date: Represents vesting of certain RSUs granted on November 22, 2016 and the consequent issuance of Common Stock of the Issuer to the Reporting Person. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. The shares of Common Stock reported in this Form 4 were issued in respect of RSUs that vested on November 22, 2017 and November 22, 2018. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis.

SEC source: 0001140361-18-043708 · form4.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 993,094

F1 · shares: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 105,896 shares of Common Stock -- granted in the form of RSUs on November 22, 2016 -- in order to satisfy those withholding tax obligations.

SEC source: 0001140361-18-043708 · form4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,098,990

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-18-036816 · form4.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 400,000 shares

Expires 2018-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options with respect to 100,000 shares vested pro rata on the first, second and third anniversaries of the date of grant. The options with respect to the remaining 300,000 shares vested upon achievement of certain milestones.

SEC source: 0001140361-18-036816 · form4.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 898,990

F1 · shares: This Form 4 reports the exercise of options for 400,000 shares of common stock of SIGA Technologies, Inc. (the "Issuer") and the related surrender to the Issuer of 234,277 shares of common stock of the Issuer by the Reporting Person in order to (i) effect the option exercise and (ii) satisfy certain tax withholding obligations of the Issuer associated with the exercise of options and the consequent issuance of common stock of the Issuer. No shares of common stock of the Issuer were sold by the Reporting Person in a market transaction.

SEC source: 0001140361-18-036816 · form4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,133,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This Form 4 reports the exercise of options for 400,000 shares of common stock of SIGA Technologies, Inc. (the "Issuer") and the related surrender to the Issuer of 234,277 shares of common stock of the Issuer by the Reporting Person in order to (i) effect the option exercise and (ii) satisfy certain tax withholding obligations of the Issuer associated with the exercise of options and the consequent issuance of common stock of the Issuer. No shares of common stock of the Issuer were sold by the Reporting Person in a market transaction.

SEC source: 0001179110-18-010525 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,183

F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders.

F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001140361-17-043229 · form4.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 465,000 shares

Expires 2019-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The SSARs vested in equal yearly installments over a period of three (3) years, with the first 1/3 of such SSARs vesting on February 2, 2013, the second 1/3 of such SSARs vesting on February 2, 2014, and the remaining 1/3 of such SSARs vesting on February 2, 2015.

SEC source: 0001140361-17-043229 · form4.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 733,267

F2 · shares: The Issuer has certain tax withholding obligations associated with the exercise of SSARs and the consequent issuance of common stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 49,446 shares of common stock otherwise issuable upon the exercise of the SSARs in order to satisfy those withholding tax obligations.

SEC source: 0001140361-17-043229 · form4.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 782,713

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This Form 4 reports the exercise of 465,000 stock-settled appreciation rights ("SSARs") for shares of common stock of SIGA Technologies, Inc. (the "Issuer"). Each SSAR consists of the right to receive an amount (the "Excess Amount"), in common stock, equal to the excess of the fair market value of one share of common stock of the Issuer (subject to a cap on the fair market value at $4.50 per share) on the date of exercise over the exercise price of such SSAR. The number of shares of common stock issued was determined by dividing the total of all exercised SSARs by the fair market value of one share of common stock of the Issuer on the date of exercise.

SEC source: 0001179110-17-011954 · edgar.xml · derivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2019-08-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.

SEC source: 0001179110-17-011954 · edgar.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,652

F2 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $145.0000 and $145.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

SEC source: 0001179110-17-011954 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-17-011866 · edgar.xml · derivative · entry 7

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 982

Underlying: Common Stock · 12,000 shares

Expires 2019-08-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.

SEC source: 0001179110-17-011866 · edgar.xml · derivative · entry 6

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2018-08-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.

SEC source: 0001179110-17-011866 · edgar.xml · nonDerivative · entry 5

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,652

F4 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $152.0200 and $153.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer..

SEC source: 0001179110-17-011866 · edgar.xml · nonDerivative · entry 4

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,252

F3 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $151.0200 and $152.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

SEC source: 0001179110-17-011866 · edgar.xml · nonDerivative · entry 3

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,273

F2 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $150.0000 and $150.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

SEC source: 0001179110-17-011866 · edgar.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-17-011866 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-17-011490 · edgar.xml · nonDerivative · entry 1

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,514

F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units

F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units

SEC source: 0001179110-17-011394 · edgar.xml · nonDerivative · entry 2

ROSE ERIC A MD · CIK 0001139301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,736

F3 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units

F3 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units